This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Walter J. Stark, MD; R. Doyle Stulting, MD, PhD; Maureen G. Maguire, PhD; (For the CCTS Research Group)
Baltimore, Md

Arch Ophthalmol. 1992;110(11):1517-1518.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Sugar appropriately emphasizes a point that we made in the "Comment" section of our article. We also mentioned two additional factors that may have contributed to the relatively high success rate for penetrating keratoplasty in the CCTS: a vigorous educational program to assure medication compliance, and frequent, regular follow-up examinations by the transplanting surgeon. The CCTS patients were outstanding in that only 4% of all visits were missed and only 1% of patients were considered unavailable for follow-up.

When we formulated the protocol for the CCTS, we were aware that high doses of postoperative steroids could mask any effect of HLA matching on corneal transplant survival. However, our goal was not to design a study that would maximize the likelihood of observing a beneficial HLA matching. Instead, we sought to determine whether HLA matching would improve graft survival when used in addition to the postoperative immunosuppressive regimen . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?